[6-K] NatWest Group plc Current Report (Foreign Issuer)
Rhea-AI Filing Summary
NatWest Group plc reports a routine share buyback transaction. On 24 November 2025, the company purchased 911,626 ordinary shares with a nominal value of £1.0769 each from Merrill Lynch International. The highest price paid was 587.80 GBp per share, the lowest was 579.80 GBp, and the volume‑weighted average price was 583.23 GBp, all on the London Stock Exchange. NatWest intends to cancel the repurchased shares. After settlement, it will hold 230,186,279 ordinary shares in treasury and have 8,016,291,743 ordinary shares in issue excluding treasury shares.
Positive
- None.
Negative
- None.
FAQ
What did NatWest Group plc (NWG) announce in this Form 6-K?
NatWest Group plc announced a transaction in its own shares, reporting the purchase of ordinary shares on 24 November 2025 as part of its share buyback activity.
How many NatWest (NWG) shares were repurchased on 24 November 2025?
NatWest repurchased 911,626 ordinary shares on 24 November 2025 from Merrill Lynch International on the London Stock Exchange.
What prices did NatWest pay for the repurchased NWG shares?
The highest price paid per share was 587.80 GBp, the lowest price was 579.80 GBp, and the volume weighted average price was 583.23 GBp.
What will NatWest Group plc do with the repurchased shares?
NatWest stated that it intends to cancel the repurchased ordinary shares, thereby permanently removing them from circulation.
How many NatWest (NWG) shares will be in issue after this buyback?
After settlement, NatWest will hold 230,186,279 ordinary shares in treasury and will have 8,016,291,743 ordinary shares in issue, excluding treasury shares.
Where can investors find the detailed trade breakdown for the NatWest buyback?
The company states that a full breakdown of individual trades made by Merrill Lynch International on behalf of NatWest is available via the referenced London Stock Exchange PDF link.
Who can investors contact at NatWest regarding this share transaction?
NatWest lists contacts for Investor Relations at +44 (0)207 672 1758 and Media Relations at +44 (0)131 523 4205 for further information.